Literature DB >> 28888955

Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse hippocampus.

Yong Li1, Jimok Kim2.   

Abstract

The effects of cannabinoids are primarily mediated by type-1 cannabinoid receptors in the brain and type-2 cannabinoid receptors (CB2Rs) in the peripheral immune system. However, recent evidence demonstrates that CB2Rs are also expressed in the brain and implicated in neuropsychiatric effects. Diverse types of cells in various regions in the brain express CB2Rs but the cellular loci of CB2Rs that induce specific behavioral effects have not been determined. To manipulate CB2R expression in specific types of cells in the dorsal hippocampus of adult mice, we used Cre-dependent overexpression and CRISPR-Cas9 genome-editing techniques in combination with adeno-associated viruses and transgenic mice. Elevation and disruption of CB2R expression in microglia in the CA1 area increased and decreased, respectively, contextual fear memory. In CA1 pyramidal neurons, disruption of CB2R expression enhanced spatial working memory, whereas their overexpression reduced anxiety levels assessed asan increase in the exploration time in the central area of open field. Interneuronal CB2Rs were not involved in the modulation of cognitive or emotional behaviors tested in this study. The targeted manipulation of CB2R expression in pyramidal neurons and microglia suggests that CB2Rs in different types of cells in the mature hippocampus play distinct roles in the regulation of memory and anxiety.
Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cnr2 gene; adeno-associated virus; behavior; memory; microglia; pyramidal neuron

Mesh:

Substances:

Year:  2017        PMID: 28888955     DOI: 10.1016/j.neuroscience.2017.08.053

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  15 in total

1.  Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS.

Authors:  Douglas J Hermes; Changqing Xu; Justin L Poklis; Micah J Niphakis; Benjamin F Cravatt; Ken Mackie; Aron H Lichtman; Bogna M Ignatowska-Jankowska; Sylvia Fitting
Journal:  Neuropharmacology       Date:  2018-08-13       Impact factor: 5.250

Review 2.  ABHD6: Its Place in Endocannabinoid Signaling and Beyond.

Authors:  Jessica K Cao; Joshua Kaplan; Nephi Stella
Journal:  Trends Pharmacol Sci       Date:  2019-03-07       Impact factor: 14.819

Review 3.  Progress in brain cannabinoid CB2 receptor research: From genes to behavior.

Authors:  Chloe J Jordan; Zheng-Xiong Xi
Journal:  Neurosci Biobehav Rev       Date:  2019-01-03       Impact factor: 8.989

4.  Gene editing vectors for studying nicotinic acetylcholine receptors in cholinergic transmission.

Authors:  Can Peng; Yijin Yan; Veronica J Kim; Staci E Engle; Jennifer N Berry; J Michael McIntosh; Rachael L Neve; Ryan M Drenan
Journal:  Eur J Neurosci       Date:  2018-07-25       Impact factor: 3.386

5.  Cannabinoid CB2 Receptor Modulation by the Transcription Factor NRF2 is Specific in Microglial Cells.

Authors:  M Galán-Ganga; R Del Río; N Jiménez-Moreno; M Díaz-Guerra; I Lastres-Becker
Journal:  Cell Mol Neurobiol       Date:  2019-08-05       Impact factor: 5.046

6.  Cannabinoid Receptors and Ligands: Lessons from CNS Disorders and the Quest for Novel Treatment Venues.

Authors:  Clara M Vecchini Rodríguez; Yma Escalona Meléndez; Jacqueline Flores-Otero
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration.

Authors:  M Galán-Ganga; C Rodríguez-Cueto; J Merchán-Rubira; F Hernández; J Ávila; M Posada-Ayala; J L Lanciego; E Luengo; M G Lopez; A Rábano; J Fernández-Ruiz; I Lastres-Becker
Journal:  Acta Neuropathol Commun       Date:  2021-05-17       Impact factor: 7.801

Review 8.  Cannabinoid Modulation of the Stressed Hippocampus.

Authors:  Franciele F Scarante; Carla Vila-Verde; Vinícius L Detoni; Nilson C Ferreira-Junior; Francisco S Guimarães; Alline C Campos
Journal:  Front Mol Neurosci       Date:  2017-12-19       Impact factor: 5.639

Review 9.  Endocannabinoids in Body Weight Control.

Authors:  Henrike Horn; Beatrice Böhme; Laura Dietrich; Marco Koch
Journal:  Pharmaceuticals (Basel)       Date:  2018-05-30

Review 10.  In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.

Authors:  Cia-Hin Lau; Yousin Suh
Journal:  F1000Res       Date:  2017-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.